ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis

Inducible T cell co-stimulator (ICOS), an immune checkpoint protein expressed on activated T cells and its unique ligand, ICOSL, which is expressed on antigen-presenting cells and non-hematopoietic cells, have been extensively investigated in the immune response. Recent findings showed that a solubl...

Descripción completa

Detalles Bibliográficos
Autores principales: Alves, Gustavo Ferreira, Stoppa, Ian, Aimaretti, Eleonora, Monge, Chiara, Mastrocola, Raffaella, Porchietto, Elisa, Einaudi, Giacomo, Collotta, Debora, Bertocchi, Ilaria, Boggio, Elena, Gigliotti, Casimiro Luca, Clemente, Nausicaa, Aragno, Manuela, Fernandes, Daniel, Cifani, Carlo, Thiemermann, Christoph, Dianzani, Chiara, Dianzani, Umberto, Collino, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479331/
https://www.ncbi.nlm.nih.gov/pubmed/36119089
http://dx.doi.org/10.3389/fimmu.2022.992614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479331/
https://www.ncbi.nlm.nih.gov/pubmed/36119089
http://dx.doi.org/10.3389/fimmu.2022.992614

Ejemplares similares